Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gahlen, Anna Maria (VerfasserIn) , Wildemann, Brigitte (VerfasserIn) , Jarius, Sven (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 16, 2017
In: Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology
Year: 2017, Jahrgang: 4, Heft: 4, Pages: 1-9
ISSN:2332-7812
DOI:10.1212/NXI.0000000000000363
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1212/NXI.0000000000000363
Volltext
Verfasserangaben:Anna Gahlen, MD, Anne-Kathrin Trampe, PhD, Steffen Haupeltshofer, MSc, Marius Ringelstein, MD, Orhan Aktas, MD, Achim Berthele, MD, Brigitte Wildemann, MD, Ralf Gold, MD, Sven Jarius, MD, Ingo Kleiter, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1576134040
003 DE-627
005 20220814154802.0
007 cr uuu---uuuuu
008 180607s2017 xx |||||o 00| ||eng c
024 7 |a 10.1212/NXI.0000000000000363  |2 doi 
035 |a (DE-627)1576134040 
035 |a (DE-576)506134040 
035 |a (DE-599)BSZ506134040 
035 |a (OCoLC)1341011202 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gahlen, Anna Maria  |d 1988-  |e VerfasserIn  |0 (DE-588)1160699607  |0 (DE-627)1024106071  |0 (DE-576)50613492X  |4 aut 
245 1 0 |a Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS  |c Anna Gahlen, MD, Anne-Kathrin Trampe, PhD, Steffen Haupeltshofer, MSc, Marius Ringelstein, MD, Orhan Aktas, MD, Achim Berthele, MD, Brigitte Wildemann, MD, Ralf Gold, MD, Sven Jarius, MD, Ingo Kleiter, MD 
264 1 |c June 16, 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.06.2018 
700 1 |a Wildemann, Brigitte  |e VerfasserIn  |0 (DE-588)110203844  |0 (DE-627)510150004  |0 (DE-576)171831330  |4 aut 
700 1 |a Jarius, Sven  |e VerfasserIn  |0 (DE-588)1054615918  |0 (DE-627)791654818  |0 (DE-576)410367478  |4 aut 
773 0 8 |i Enthalten in  |t Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology  |d Philadelphia, Pa. : Wolters Kluwer, 2014  |g 4(2017), 4, Seite 1-9  |h Online-Ressource  |w (DE-627)784191956  |w (DE-600)2767740-0  |w (DE-576)404866883  |x 2332-7812  |7 nnas  |a Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS 
773 1 8 |g volume:4  |g year:2017  |g number:4  |g pages:1-9  |g extent:9  |a Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS 
856 4 0 |u https://doi.org/10.1212/NXI.0000000000000363  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180607 
993 |a Article 
994 |a 2017 
998 |g 1054615918  |a Jarius, Sven  |m 1054615918:Jarius, Sven  |d 910000  |d 911100  |e 910000PJ1054615918  |e 911100PJ1054615918  |k 0/910000/  |k 1/910000/911100/  |p 9 
998 |g 110203844  |a Wildemann, Brigitte  |m 110203844:Wildemann, Brigitte  |d 910000  |d 911100  |e 910000PW110203844  |e 911100PW110203844  |k 0/910000/  |k 1/910000/911100/  |p 7 
999 |a KXP-PPN1576134040  |e 3012037950 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 28.04.14"],"id":{"eki":["784191956"],"issn":["2332-7812"],"zdb":["2767740-0"]},"part":{"extent":"9","text":"4(2017), 4, Seite 1-9","issue":"4","pages":"1-9","volume":"4","year":"2017"},"title":[{"title_sort":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","title":"Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology"}],"origin":[{"dateIssuedKey":"2014","publisherPlace":"Philadelphia, Pa. ; Philadelphia, Pa.","dateIssuedDisp":"2014-","publisher":"Wolters Kluwer ; Lippincott Williams & Wilkins"}],"pubHistory":["1.2014 -"],"disp":"Aquaporin-4 antibodies in patients treated with natalizumab for suspected MSNeurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology","physDesc":[{"extent":"Online-Ressource"}],"recId":"784191956"}],"person":[{"family":"Gahlen","given":"Anna Maria","role":"aut","display":"Gahlen, Anna Maria"},{"display":"Wildemann, Brigitte","family":"Wildemann","given":"Brigitte","role":"aut"},{"display":"Jarius, Sven","given":"Sven","role":"aut","family":"Jarius"}],"origin":[{"dateIssuedDisp":"June 16, 2017","dateIssuedKey":"2017"}],"note":["Gesehen am 07.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"title":[{"title_sort":"Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS","title":"Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS"}],"physDesc":[{"extent":"9 S."}],"recId":"1576134040","name":{"displayForm":["Anna Gahlen, MD, Anne-Kathrin Trampe, PhD, Steffen Haupeltshofer, MSc, Marius Ringelstein, MD, Orhan Aktas, MD, Achim Berthele, MD, Brigitte Wildemann, MD, Ralf Gold, MD, Sven Jarius, MD, Ingo Kleiter, MD"]},"id":{"doi":["10.1212/NXI.0000000000000363"],"eki":["1576134040"]}} 
SRT |a GAHLENANNAAQUAPORIN41620